Navigation Links
National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients

MADISON, Wis. Jan. 12, 2009 The 2009 winners of the National Lung Cancer Partnership/LUNGevity Foundation Research Grants are Prasad Adusumilli, M.D. and Lee Goodglick, Ph.D. The $100,000 grants will fund the scientist's research on visceral pleural invasion and the role of estrogen in lung cancer tumors, respectively.

Dr. Adusumilli, a general thoracic surgeon specializing in lung cancer at Memorial Sloan-Kettering Cancer Center in New York, was awarded the grant focused on basic research for his proposed study of Visceral Pleural Invasion, a condition that affects one in four early stage lung cancer patients in which their cancer spreads to the membrane covering the lungs surface and is associated with poorer treatment outcomes.

Using a mouse model, Dr. Adusumilli's will use genetic engineering to program immune cells to target and suppress tumor cells on the lung membrane.

Dr. Goodglick of the David Geffen School of Medicine at the University of California, Los Angeles was awarded the grant for research in the area of sex differences in lung cancer. His research will focus on estrogen, which many lung cancers either make or are responsive to, similarly to breast cancer. Aromatase-inhibitors, drugs which turn off the enzyme aromatase which can cause some cancers to grow and have long been used in breast cancer treatment, will be studied in a pre-clinical trial to determine their effectiveness in treating lung cancer. Additional research will use new technology to address other ways that estrogen may affect lung cancer in order to identify future therapies.

"Only by continuing to fund this type of lung cancer research can we keep the momentum towards better treatments for patients," Dr. Joan Schiller, president of the National Lung Cancer Partnership and chief of hematology/oncology of the University of Texas Southwestern Medical Center said. "Supporting the work of scientists like Drs. Adusumilli and Goodglick is critical to our continued battle against the world's number 1 cancer killer."


Contact: Colleen O'Donnell
National Lung Cancer Partnership

Related biology news :

1. Landmark national study reveals significance of green practices in attractions industry
2. International experts weigh-in on harmful algal blooms
3. International copper industry defines role in the fight against hospital infections
4. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
5. International public-private partnership offers new paradigm for medicinal chemistry
6. Childrens National convenes first childhood obesity symposium
7. The International Society for Stem Cell Research releases new guidelines
8. Endangered sawfish focus of national collection and recovery efforts
9. New national park protects worlds rarest gorilla
10. Lab test for allergy scoops national
11. Halas wins high-profile national security award
Post Your Comments:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
Breaking Biology Technology: